References

Akdis, C., M. Akdis et al. (2006). Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/ PRACTALL Consensus Report. Allergy, 61(8): 969–987.

All Party Parliamentary Group on Skin (2006). Report on the enquiry into the adequacy and equity of dermatology services in the United Kingdom. London: APPGS.

Bettzuege-Pfaff, B. and A. Melzer (2005). Treating dry skin and pruritus with a bath oil containing soya oil and lauromacragols. Current Medical Research and Opinion, 21(11): 173501739.

British Medical Association and Royal Pharmaceutical Society of Great Britain (2007). British National Formulary 54. Retrieved 7/01/08, 2007, from www.bnf.org.

Britton, J. (2003). The use of emollients and their correct application. Journal of Community Nursing, 17(9): 22–25.

Cork, M.J. (1997). The importance of skin barrier function. Journal of Dermatological Treatment, 8: s7–s13.

Cork, M.J., J. Timmins et al. (2003). An audit of adverse drug reactions to aqueous cream in children with atopic eczema. The Pharmaceutical Journal, 271: 747–748.

de Groot, A. (2000). Sensitizing substances. In: Loden, M., Maibach, H. (Eds), Dry Skin and Moisturizers. Boca Raton: CRC Press.

Drugs and Therapeutics Bulletin (2007). Bath emollients for atopic eczema: Why use them? Drugs and Therapeutics Bulletin, 45(10): 73–75.

Ersser, S., S. Maguire et al. (2007). A Best Practice Statement for Emollient Therapy. Retrieved 7 January 2008, from www. dermatology-uk.com/educational_projects. shtml.

Finlay, A.Y. (1997). Emollients as adjuvant therapy for psoriasis. Journal of Dermatological Treatment, 8: s25–s27.

Grimalt, R., U. Mengeaud et al. (2007). The steroid sparing effect of emollient therapy in infants with atopic dermatitis: A randomised controlled study. Dermatology, 214(1): 61–67.

Hall, M. (2003). Target skin. In: Kirkness, B. (Ed.). London: The Association of the British Pharmaceutical Industry.

Hanifin, J., A. Herbert et al. (1998). Effects of a low potency corticosteroid lotion plus a moisturizing regimen in the treatment of atopic dermatitis. Current Therapeutic Research Clinical and Experimental, 59(4): 227–233.

Harris, I. and U. Hoppe (2000). Lanolins. In: Loden, M., Maibach, H. (Eds), Dry Skin and Moisturizers – Chemistry and Function. Boca Raton: CRC Press.

Holden, C., J. English et al. (2002). Advised best practice for the use of emollients in eczema and other dry skin conditions. Journal of Dermatological Treatment, 13(3): 103–106.

Kligman, A.M. (2000). Introduction. In: Loden, M., Maibach, H. (Eds), Dry Skin and Moisturizers: Chemistry and Function. Boca Raton: CRC Press.

Loden, M. and H. Maibach, Eds (2000). Dry skin and moisturizers: Chemistry and function. Boca Raton, CRC Press.

Lucky, A.W., A.D. Leach et al. (1997). Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Paediatric Dermatology, 14(4): 321–324.

Marks, R. (2001). Sophisticated Emollients. Stuttgart: Thieme.

National Institute for Clinical Excellence (2001). Referral Advice: A Guide to Appropriate Referral from General to Specialist Services. London: NICE.

Nicol, N. and M. Boguniewicz (2008). Successful strategies in atopic dermatitis management. Dermatology Nursing, Oct(Suppl): 3–18.

Nicol, N., A. Ruszkowski et al. (1995). Contact dermatitis and the role of patch testing in its diagnosis and management. Dermatology Nursing, Feb(Suppl): 5–27.

Penzer, R. (2005). What advice do nurses working with adult patients with moderate plaque psoriasis give on the use of topical emollients? Dermatological Nursing, 4(4): 21–22.

Rawlings, A.V., D.A. Canestrari et al. (2004). Moisturizer technology versus clinical performance. Dermatologic Therapy, 17(Suppl 1): 49–56.

Smoker, A. (2007). Topical steroid or emollient – Which one do you apply first? An investigation into the sequencing of topical steroid and emollient application and the most clinically effective method of application. University of Southampton.

Stone, L. (2000). Medilan: A hypoallergenic lanolin for emollient therapy. British Journal of Nursing, 9(1): 54–57.


Tree, S. and R. Marks (1975). An explanation for the ‘placebo’ effect of bland ointment bases. British Journal of Dermatology, 92: 195–198.

Voegeli, D. (2007). Factors that exacerbate skin breakdown and ulceration. In: Pownell, M. (Ed.), Skin Breakdown – The Silent Epidemic, pp. 17–22. Hull: The Smith and Nephew Foundation.

Watsky, K.L., L. Freije et al. (1992). Waterin- oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis. Cutis, 50: 383–386.

Wood, L., P. Elias et al. (1996). Barrier disruption stimulate interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. Journal of Investigative Dermatology, 106(3): 397–403.